Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Chemomab Therapeutics Ltd. buy BiotechBee

Chemomab Therapeutics Ltd.
Start price
€1.19
09.03.25 / 60%
Target price
€2.50
31.07.27
Performance (%)
-16.39%
End price
€1.00
30.03.25
Summary
This prediction ended on 30.03.25 with a price of €1.00. The prediction for Chemomab Therapeutics Ltd. disappointed with a performance of -16.39%. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m
Chemomab Therapeutics Ltd. - -
iShares Core DAX® 0.734% -0.964%
iShares Nasdaq 100 -2.686% -2.409%
iShares Nikkei 225® -2.261% -4.038%
iShares S&P 500 -1.346% -1.510%

According to BiotechBee what are the pros and cons of Chemomab Therapeutics Ltd. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Chemomab Therapeutics Ltd. diskutieren
Prediction Buy
Perf. (%) -16.39%
Target price 2.500
Change
Ends at 31.07.27

Buy mit Kursziel 2,5

BiotechBee 
0
Report Share
09.03.25
In the thread Trading Chemomab Therapeutics Ltd.
Prediction Buy
Perf. (%) -16.39%
Target price 2.500
Change
Ends at 31.07.27

Buy beendet

BiotechBee 
0
Report Share
30.03.25

Stopped prediction by BiotechBee for Chemomab Therapeutics Ltd.

buy
Chemomab Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.74
08.09.24
€3.20
29.11.26
-12.64%
14.12.24

Could be very worthwhile Investment >20% year
BiotechBee 
08.09.24 50%